SILK News and Press, Silk Road Medical Inc.

2024-06-24 15:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MONSEY, N.Y., June 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $27.50 per share in cash for which Silk Road Medical, Inc. (Nasdaq: SILK) (“SILK”) has agreed to be sold to Boston Scientific Corporation (“Bo...

NEW YORK, NY / ACCESSWIRE / June 20, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Silk Road Medical, Inc. (NASDAQ:SILK)...

2024-06-20 09:21:07 ET Summary Boston Scientific Corp announced the acquisition of Silk Road Medical for $1.16 billion, valuing Silk Road Medical, Inc’s shares at $27.5, 27% higher than the previous share price. Boston Scientific is also in the process of acquiring Axonics,...

Silk Road Medical, Inc (NASDAQ: SILK) is one of today's top gainers. The company's shares have moved 24.02% on the day to $26.88. Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease c...

2024-06-18 11:15:04 ET Lake Street analyst issues HOLD recommendation for SILK on June 18, 2024 09:43AM ET. The previous analyst recommendation was Buy. SILK was trading at $26.805 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current a...

2024-06-18 11:00:05 ET Frank Takkinen from Lake Street issued a price target of $27.50 for SILK on 2024-06-18 09:43:00. The adjusted price target was set to $27.50. At the time of the announcement, SILK was trading at $26.805. The overall price target consensus is at $31...

2024-06-18 07:24:06 ET Boston Scientific ( NYSE: BSX ) on Tuesday announced a deal to acquire medical device company Silk Road Medical ( NASDAQ: SILK ) for $27.50 a share, representing an enterprise value of approximately $1.16B.... Read the full article on Seeking...

Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc. PR Newswire Acquisition adds innovative technology for stroke prevention to vascular portfolio MARLBOROUGH, Mass. , June 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE:...

Boston Scientific to acquire Silk Road Medical for $27.50 per share in cash SUNNYVALE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (“Silk Road”) (NASDAQ:SILK), a leading minimally invasive medical device company for carotid artery procedures, announced ...